BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 29254811)

  • 1. Analysis on clinical characteristics and drug resistance of Candida parapsilosis bloodstream infections in West China Hospital, China, from 2012 to 2015.
    Liu Y; Kang M; Ye H; Zong Z; Lv X
    J Mycol Med; 2018 Mar; 28(1):222-226. PubMed ID: 29254811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
    Iatta R; Caggiano G; Cuna T; Montagna MT
    J Chemother; 2011 Apr; 23(2):92-6. PubMed ID: 21571625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
    Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
    PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
    Taj-Aldeen SJ; Kolecka A; Boesten R; Alolaqi A; Almaslamani M; Chandra P; Meis JF; Boekhout T
    Infection; 2014 Apr; 42(2):393-404. PubMed ID: 24352810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
    Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
    J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
    Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina.
    Vigezzi C; Icely PA; Dudiuk C; Rodríguez E; Miró MS; Castillo GDV; Azcurra AI; Abiega C; Caeiro JP; Riera FO; García-Effrón G; Sotomayor CE
    J Mycol Med; 2019 Dec; 29(4):285-291. PubMed ID: 31668524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
    Lindberg E; Hammarström H; Ataollahy N; Kondori N
    Sci Rep; 2019 Mar; 9(1):3838. PubMed ID: 30846717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.
    Martí-Carrizosa M; Sánchez-Reus F; March F; Coll P
    Scand J Infect Dis; 2014 Jun; 46(6):454-61. PubMed ID: 24762093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Diversity and Antifungal Susceptibility of Candida parapsilosis Sensu Stricto Isolated from Bloodstream Infections in Turkish Patients.
    Hilmioğlu-Polat S; Sharifynia S; Öz Y; Aslan M; Gündoğdu N; Serin A; Rafati H; Mohammadi F; Yeşim-Metin D; Döğen A; Ilkit M; Seyedmousavi S
    Mycopathologia; 2018 Aug; 183(4):701-708. PubMed ID: 29725811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.
    Wisplinghoff H; Ebbers J; Geurtz L; Stefanik D; Major Y; Edmond MB; Wenzel RP; Seifert H
    Int J Antimicrob Agents; 2014 Jan; 43(1):78-81. PubMed ID: 24182454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and antifungal susceptibility patterns of candidemia from a tertiary centre in Western Australia.
    Boan P; Gardam D
    J Chemother; 2019 May; 31(3):137-140. PubMed ID: 30955472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.
    Khodavaisy S; Badali H; Meis JF; Modiri M; Mahmoudi S; Abtahi H; Salehi M; Dehghan Manshadi SA; Aala F; Agha Kuchak Afshari S; Lotfali E; Ahangarkani F; Rezaie S
    J Mycol Med; 2020 Sep; 30(3):100968. PubMed ID: 32386800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy.
    Zhang L; Xiao M; Watts MR; Wang H; Fan X; Kong F; Xu YC
    BMC Infect Dis; 2015 Aug; 15():340. PubMed ID: 26282840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
    Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
    Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, virulence factors and antifungal susceptibility of Candida spp. isolated from bloodstream infections in a tertiary care hospital in Brazil.
    Canela HMS; Cardoso B; Vitali LH; Coelho HC; Martinez R; Ferreira MEDS
    Mycoses; 2018 Jan; 61(1):11-21. PubMed ID: 28940753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidaemia due to Candida parapsilosis species complex at a hospital in Brazil: Clinical characteristics and antifungal susceptibility profile.
    Alencar DSO; Tsujisaki RAS; Spositto FLE; Nunes MO; Almeida AA; Martins MDA; Melhem MSC; Chang MR
    Rev Iberoam Micol; 2017; 34(2):106-108. PubMed ID: 28214273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bloodstream yeast infections in a university hospital in Northeast Turkey: a 4-year survey.
    Aydin F; Bayramoglu G; Guler NC; Kaklikkaya N; Tosun I
    Med Mycol; 2011 Apr; 49(3):316-9. PubMed ID: 20807028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility of bloodstream Candida isolates in Sfax hospital: Tunisia.
    Sellami A; Sellami H; Néji S; Makni F; Abbes S; Cheikhrouhou F; Chelly H; Bouaziz M; Hammami B; Ben Jemaa M; Khaled S; Ayadi A
    Mycopathologia; 2011 Jun; 171(6):417-22. PubMed ID: 21170738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.